TC Biopharm (Holdings) Plc
TCBPY
$0.30
-$0.1898-38.75%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -301.64% | -446.34% | -262.55% | -268.64% | 285.84% |
| Total Depreciation and Amortization | -24.29% | -26.67% | -13.24% | -11.78% | -35.55% |
| Total Amortization of Deferred Charges | -- | -- | -57.14% | -54.76% | -- |
| Total Other Non-Cash Items | 102.71% | 128.89% | 498.69% | 505.27% | -18.90% |
| Change in Net Operating Assets | -109.19% | -95.92% | 115.79% | 116.06% | 56.25% |
| Cash from Operations | 30.06% | 13.60% | 33.98% | 32.87% | 11.81% |
| Capital Expenditure | 45.66% | -- | 122.07% | 122.46% | -813.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 71.84% | 76.64% | 16.89% | 15.23% | 10.24% |
| Cash from Investing | 57.70% | 95.98% | 103.72% | 103.79% | -74.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 213.07% | 213.07% | -- |
| Issuance of Common Stock | 126,545.45% | -30.08% | 724.11% | 724.11% | -99.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -102.94% | -88.48% | -88.48% | -96.54% |
| Cash from Financing | 1,164.32% | -75.37% | -12.78% | -11.31% | -96.64% |
| Foreign Exchange rate Adjustments | -- | -- | 115.58% | 115.88% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.62% | -272.35% | 148.38% | 149.19% | -270.30% |